Aggressive NK-cell leukemia
| Aggressive NK-cell leukemia | |
|---|---|
![]() | |
| Synonyms | N/A |
| Pronounce | N/A |
| Specialty | N/A |
| Symptoms | Fever, weight loss, night sweats, hepatosplenomegaly, lymphadenopathy |
| Complications | Hemophagocytic lymphohistiocytosis, multi-organ failure |
| Onset | Typically in young adults |
| Duration | Acute |
| Types | N/A |
| Causes | Genetic mutations, Epstein-Barr virus |
| Risks | Immunosuppression, Asian descent |
| Diagnosis | Blood test, bone marrow biopsy, immunophenotyping |
| Differential diagnosis | T-cell leukemia, B-cell lymphoma, infectious mononucleosis |
| Prevention | N/A |
| Treatment | Chemotherapy, hematopoietic stem cell transplantation |
| Medication | N/A |
| Prognosis | Poor |
| Frequency | Rare |
| Deaths | N/A |
| Aggressive NK-cell leukemia | |
|---|---|
| ICD-10 | |
| ICD-9 | |
| DiseasesDB | |
| MedlinePlus | |
| eMedicine | |
| MeSH ID | |
Aggressive NK-cell leukemia is a rare and rapidly progressing form of leukemia characterized by the proliferation of natural killer cells. It is considered a subtype of large granular lymphocyte leukemia.
Signs and Symptoms[edit]
Patients with aggressive NK-cell leukemia often present with systemic symptoms such as fever, weight loss, night sweats, and fatigue. Other symptoms may include hepatosplenomegaly and lymphadenopathy.
Complications[edit]
This condition can lead to severe complications, including hemophagocytic lymphohistiocytosis (HLH), a life-threatening condition characterized by excessive immune activation and organ failure.
Causes[edit]
The exact cause of aggressive NK-cell leukemia is not well understood, but it is often associated with genetic mutations and viral infections, particularly the Epstein-Barr virus (EBV).
Diagnosis[edit]
Diagnosis typically involves a combination of blood tests, bone marrow biopsy, and immunophenotyping to identify the abnormal NK cells. Cytogenetic analysis may also be performed to detect specific genetic abnormalities.
Treatment[edit]
Treatment options are limited and often include chemotherapy and stem cell transplant. The prognosis for aggressive NK-cell leukemia is generally poor, with a high rate of relapse and resistance to treatment.
Epidemiology[edit]
Aggressive NK-cell leukemia is a rare disease, with a higher prevalence in East Asia. It affects both children and adults, with a slight male predominance.
See Also[edit]
References[edit]
External Links[edit]
- National Cancer Institute - NK-cell leukemia treatment
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
